Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age26-32
SponsorCHRISTUS Health

About this trial

Study focuses on determining if daily versus every-other-day (EOD) oral iron at the same dose per kilogram per day will achieve similar incidence of iron replete status at 36 weeks post-menstrual age in premature neonates

Eligibility criteria

Qualifiers

Children (Minor < 18 years of age)

Neonates

Hospitalized

Premature infants who are on full enteral feeds and are started on oral iron

Disqualifiers

None

Trial design

Treatments tested in this trial

  • 6 mg/kg of oral iron as ferrous sulfate administered every other day.
  • 6 mg/kg of oral iron as ferrous sulfate administered every day.

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators